In a single experiment, scientists can decipher the entire genomes of many patient samples, animal models, or cultured cells.
Morning Overview on MSN
New tool automates key steps in genome sequencing analysis
A Snakemake-based pipeline called Pipeasm automates key steps of genome assembly, from raw read trimming through scaffolding ...
Living with a rare disease often means years of uncertainty, misdiagnosis, and limited treatment options. But advances in ...
PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced that Basecamp Research, a frontier AI lab for therapeutic design, has selected PacBio HiFi ...
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
Zacks Investment Research on MSN
NTRA debuts Zenith Genomics next-gen sequencing test for rare diseases
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...
For the tens of millions of Americans affected by a rare disease, their genes often hold the key to getting the answers they desperately need; from helping them obtain an accurate diagnosis, to ...
Researchers at Inocras, a bioinformatics-led precision health company harnessing the power of whole-genome sequencing (WGS) ...
Foundation Medicine, Inc., a global precision medicine company, today announced the launch of its Whole Genome Sequencing (WGS) Germline test for research use. This important portfolio expansion is ...
The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly among children with autism spectrum disorder (ASD) and other neurogenetic ...
Local genomic testing will cut wait times and uncertainty for cancer patients, Health Minister Simeon Brown says. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results